These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 22113154

  • 1. When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature.
    Manu P, Sarpal D, Muir O, Kane JM, Correll CU.
    Schizophr Res; 2012 Feb; 134(2-3):180-6. PubMed ID: 22113154
    [Abstract] [Full Text] [Related]

  • 2. Clozapine Rechallenge After Major Adverse Effects: Clinical Guidelines Based on 259 Cases.
    Manu P, Lapitskaya Y, Shaikh A, Nielsen J.
    Am J Ther; 2018 Feb; 25(2):e218-e223. PubMed ID: 29505490
    [Abstract] [Full Text] [Related]

  • 3. Clozapine Rechallenge Following Neuroleptic Malignant Syndrome: A Systematic Review.
    Lally J, McCaffrey C, OʼMurchu C, Krivoy A, Guerandel A, MacCabe JH, Gaughran F.
    J Clin Psychopharmacol; 2019 Feb; 39(4):372-379. PubMed ID: 31205196
    [Abstract] [Full Text] [Related]

  • 4. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
    Simon L, Cazard F.
    Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327
    [Abstract] [Full Text] [Related]

  • 5. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
    Meyer N, Gee S, Whiskey E, Taylor D, Mijovic A, Gaughran F, Shergill S, MacCabe JH.
    J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037
    [Abstract] [Full Text] [Related]

  • 6. Clinical determinants of fever in clozapine users and implications for treatment management: A narrative review.
    Verdoux H, Quiles C, de Leon J.
    Schizophr Res; 2019 Sep; 211():1-9. PubMed ID: 31378552
    [Abstract] [Full Text] [Related]

  • 7. Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review.
    Corbeil O, Béchard L, Fournier É, Plante M, Thivierge MA, Lafrenière CÉ, Huot-Lavoie M, Brodeur S, Essiambre AM, Roy MA, Demers MF.
    J Psychopharmacol; 2023 Apr; 37(4):370-377. PubMed ID: 36794520
    [Abstract] [Full Text] [Related]

  • 8. Clozapine-Associated Myocarditis: A Protocol for Monitoring Upon Clozapine Initiation and Recommendations for How to Conduct a Clozapine Rechallenge.
    Griffin JM, Woznica E, Gilotra NA, Nucifora FC.
    J Clin Psychopharmacol; 2023 Apr; 41(2):180-185. PubMed ID: 33587399
    [Abstract] [Full Text] [Related]

  • 9. Rapid Rechallenge with Clozapine Following Pronounced Myocarditis in a Treatment-Resistant Schizophrenia Patient.
    Ittasakul P, Archer A, Kezman J, Atsariyasing W, Goldman MB.
    Clin Schizophr Relat Psychoses; 2016 Apr; 10(2):120-2. PubMed ID: 27440213
    [Abstract] [Full Text] [Related]

  • 10. Successful rechallenge after clozapine-associated myocarditis.
    Holden J, Begum M.
    BMJ Case Rep; 2022 May 12; 15(5):. PubMed ID: 35550318
    [Abstract] [Full Text] [Related]

  • 11. Successful clozapine rechallenge in a patient with suspected drug induced lupus.
    Pathak S, Cherry S, Samad S, Aftab A.
    BMJ Case Rep; 2019 Apr 03; 12(4):. PubMed ID: 30948402
    [Abstract] [Full Text] [Related]

  • 12. Rechallenging clozapine after neuroleptic malignant syndrome.
    Anbalagan E, Ithman M, Lauriello J.
    Psychiatr Q; 2014 Sep 03; 85(3):345-8. PubMed ID: 24633526
    [Abstract] [Full Text] [Related]

  • 13. The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic Review.
    Lally J, Malik S, Krivoy A, Whiskey E, Taylor DM, Gaughran FP, Flanagan RJ, Mijovic A, MacCabe JH.
    J Clin Psychopharmacol; 2017 Oct 03; 37(5):600-604. PubMed ID: 28817489
    [Abstract] [Full Text] [Related]

  • 14. Protocol for Clozapine Rechallenge in a Case of Clozapine-Induced Myocarditis.
    Shivakumar G, Thomas N, Sollychin M, Takács A, Kolamunna S, Melgar P, Connally F, Neil C, Bousman C, Jayaram M, Pantelis C.
    Can J Psychiatry; 2020 Jul 03; 65(7):448-453. PubMed ID: 31818135
    [Abstract] [Full Text] [Related]

  • 15. Clozapine-induced myocarditis and patient outcomes after drug rechallenge following myocarditis: A systematic case review.
    Richardson N, Greenway SC, Bousman CA.
    Psychiatry Res; 2021 Nov 03; 305():114247. PubMed ID: 34715441
    [Abstract] [Full Text] [Related]

  • 16. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
    Myles N, Myles H, Clark SR, Bird R, Siskind D.
    Aust N Z J Psychiatry; 2017 Oct 03; 51(10):980-989. PubMed ID: 28747065
    [Abstract] [Full Text] [Related]

  • 17. Lithium and clozapine rechallenge: a retrospective case analysis.
    Kanaan RA, Kerwin RW.
    J Clin Psychiatry; 2006 May 03; 67(5):756-60. PubMed ID: 16841625
    [Abstract] [Full Text] [Related]

  • 18. Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?
    Nielsen J, Correll CU, Manu P, Kane JM.
    J Clin Psychiatry; 2013 Jun 03; 74(6):603-13; quiz 613. PubMed ID: 23842012
    [Abstract] [Full Text] [Related]

  • 19. Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014.
    Hollingworth SA, Winckel K, Saiepour N, Wheeler AJ, Myles N, Siskind D.
    Psychopharmacology (Berl); 2018 Jul 03; 235(7):1915-1921. PubMed ID: 29589067
    [Abstract] [Full Text] [Related]

  • 20. Clozapine-induced neuroleptic malignant syndrome: clozapine monotherapy rechallenge in a case of previous NMS.
    Illing M, Ancill R.
    Can J Psychiatry; 1996 May 03; 41(4):258. PubMed ID: 8726793
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.